Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?
- 31 January 2013
- journal article
- other
- Published by Elsevier BV in Lung Cancer
- Vol. 79 (1), 94-95
- https://doi.org/10.1016/j.lungcan.2012.09.017
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking StatusPLOS ONE, 2012
- Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokersLung Cancer, 2012
- Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic OpportunitiesClinical Cancer Research, 2012
- ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous CarcinomaJournal of Thoracic Oncology, 2012
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 MutationsClinical Cancer Research, 2012
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2010